The Insight Dental Implant System is intended for use in the mandible or maxilla as an artificial root structure for single tooth replacement or fixed bridgework and dental retention. The Insight Dental Implant System is intended for delayed loading.

Device Description

The Insight Dental Implant System is an integrated system of endosseous dental implants which are designed to support prosthetic devices for partially or fully endetulous patients. The Insight Dental Implant System consists of one-stage and two-stage root form dental implants and abutments, which provide the dentist with screw retained restoration options. The devices covered by this submission are implants, abutments, and healing caps. Implants are manufactured from titanium and feature a blasted finish on the threaded screw surface. The implants are provided in bone level and tissue level. The diameters of the implant fixtures are 3.5mm, 3.8mm, 4.6mm and 5.4mm; the lengths are 8.0mm, 10.0mm, and 12.0mm and is defined as the threaded implanted portion of the implant. Abutments are available in both standard and angled configurations. Abutments are manufactured from titanium. Standard abutments are straight, 4.6mm in diameter and sized for every implant diameter including 3.5mm, 4.6mm and 5.4mm. Angled abutments are 17°, 4.9mm in diameter and sized for every implant diameter including 3.5mm, 3.8mm, 4.6mm and 5.4mm. Healing caps are manufactured from titanium. The diameter of each healing cap matches an implant at 3.5mm, 3.8mm, 4.6mm and 5.4mm. Healing caps are straight. The dental implants provided consist of a straight wall or tapered body type with a basic screw-type design in various platform options and feature an internal connection and antirotation feature. Insight Dental Implant System is available with either prevail platform switching feature or standard collar. The Insight Dental System is packaged in a two section sterile tray with all of the implants and instruments needed for a single procedure included. All components of the system are intended for single use only.

AI/ML Overview

The provided text is a 510(k) Premarket Notification for the Insight Dental Implant System. It primarily focuses on demonstrating substantial equivalence to predicate devices based on design, materials, and mechanical testing. The document does not contain information about a study proving the device meets acceptance criteria related to a machine learning or AI-driven system.

Therefore, I cannot provide the requested information about acceptance criteria and a study proving a device meets acceptance criteria using AI performance metrics, as the document does not describe such a study.

Here's a breakdown of why the requested information cannot be extracted from the provided text:

Nature of the Device: The Insight Dental Implant System is described as an artificial root structure, consisting of physical implants, abutments, and healing caps made of titanium. It is a mechanical device, not an AI or software-based medical device.
Study Type: The "Summary of Testing" section (page 7) details tests related to:
- Mechanical Properties: Comparative Dynamic Fatigue testing (ISO-14801-2007).
- Material Analysis: Surface treatment (SEM, X-ray spectroscopy, auger electron spectroscopy).
- Biocompatibility: Cytotoxicity testing (ISO 10993-5).
- Shelf Life: Accelerated aging (ASTM F1980-07).
- Sterility: Gamma irradiation (ISO 1137-1).
Absence of AI/ML Information: There is no mention of algorithms, machine learning, AI, image analysis software, diagnostic performance in terms of sensitivity/specificity, or human reader studies. The "device performance" described is mechanical and material-specific.
Ground Truth: The "ground truth" for these tests would be established by physical measurements, chemical analysis, and standardized mechanical test results, not expert consensus on interpretations of data (which would be relevant for an AI system).
Clinical Data: The document explicitly states: "No clinical test data was used to support the decision of substantial equivalence." This further indicates the absence of human-in-the-loop or standalone AI performance studies which typically involve clinical data.

In summary, the provided document does not describe the type of product or study that would generate the information you've requested regarding AI acceptance criteria and performance.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an emblem featuring a stylized caduceus, which is a symbol often associated with healthcare and medicine. The caduceus is depicted with a staff entwined by two snakes and topped with wings.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 27, 2017

Insight Dental System c/o David Furr Regulatory Correspondent FDC Services 8708 Capehart Cove Austin, Texas 78733

Re: K170211

Trade/Device Name: Insight Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: March 31, 2017 Received: April 3, 2017

Dear David Furr:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Michael J. Ryan -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K170211

Device Name Insight Dental Implant System

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

{3}------------------------------------------------

510(k) Summary Pursuant to 21 CFR 807.92

Date: April 17, 2017 K170211

1.	Submitted By:	Insight Dental System4766 Research DriveSan Antonio, Texas 78240888-255-7935
2.	Contact:	David C. FurrFDC Services, LLC8708 Capehart CoveAustin, Texas 78733512-906-9654
3.	Product:	Insight Dental Implant SystemRegulation:21CFR§872.3640 Class IIProduct Codes:DZE Implant, Endosseous, Root FormNHA Abutment, Implant, Dental, Endosseous
4.	Trade Name:Common Name:Regulation Name:	Insight Dental Implant SystemDental Implant & Abutment SystemEndosseous Dental Implant
5.	Primary Predicate:	BioHorizons Tapered Internal Implants K143022
6.	Reference Predicates:	BioHorizons Laser-Lok 3.0 Implant System K093321BioHorizons Tapered Internal Implant System K071638

Description:

Implants are manufactured from titanium and feature a blasted finish on the threaded screw surface. The implants are provided in bone level and tissue level. The diameters of the implant fixtures are 3.5mm, 3.8mm, 4.6mm and 5.4mm; the lengths are 8.0mm, 10.0mm, and 12.0mm and is defined as the threaded implanted portion of the implant.

{4}------------------------------------------------

510(k) Premarket Notification Insight Dental Implant System

Abutments are available in both standard and angled configurations. Abutments are manufactured from titanium. Standard abutments are straight, 4.6mm in diameter and sized for every implant diameter including 3.5mm, 4.6mm and 5.4mm. Angled abutments are 17°, 4.9mm in diameter and sized for every implant diameter including 3.5mm, 3.8mm, 4.6mm and 5.4mm.

Healing caps are manufactured from titanium. The diameter of each healing cap matches an implant at 3.5mm, 3.8mm, 4.6mm and 5.4mm. Healing caps are straight.

The dental implants provided consist of a straight wall or tapered body type with a basic screw-type design in various platform options and feature an internal connection and antirotation feature. Insight Dental Implant System is available with either prevail platform switching feature or standard collar.

The Insight Dental System is packaged in a two section sterile tray with all of the implants and instruments needed for a single procedure included. All components of the system are intended for single use only.

Indications for Use:

The Insight Dental Implant System is intended for use in the mandible or maxilla as an artificial root structure for single tooth replacement or for fixed bridgework and dental retention. The Insight Dental Implant System is intended for delayed loading.

Substantial Equivalence/Technological Characteristics:

The subject device is substantially equivalent to the BioHorizons Tapered Internal Implant System which is based on BioHorizons premarket notification (K143022). BioHorizon premarket notifications K071638 and K093321 were also used as reference predicate devices.

The subject device and the predicate devices have a similar intended use, design, technological characteristics, principals of operation, and are made of the same materials. The subject device and predicate devices encompass a similar range of physical dimensions, including diameter and length of the implants and diameter, height, and angle of the abutments. The subject and predicate devices are packaged in similar materials and sterilized using irradiation. Any differences do not raise new issues of substantial equivalence.

{5}------------------------------------------------

510(k) Premarket Notification Insight Dental Implant System

Element ofComparison	510(k) Device:Insight Dental System	Primary Predicate Device:BioHorizons Tapered InternalImplant System K143022	Reference Device:BioHorizons Laser-Lok 3.0Implant System K093321	Reference Device:BioHorizons TaperedInternal Implant SystemK071638	Explanation ofDifferences
Regulation andProductClassificationCode	21 CFR 872.3640DZENHA	21 CFR 872.3640DZE21 CFR 872.3630NHA	21 CFR 872.3640DZE21 CFR 872.3630NHA	21 CFR 872.3640DZE21 CFR 872.3630NHA	None
Indications for Use	The Insight Dental ImplantSystem is intended for use inthe mandible or maxilla as anartificial root structure forsingle tooth replacement orfor fixed bridgework anddental retention. The InsightDental Implant System isintended for delayed loading.	The BioHorizonsTapered Internal ImplantSystem is intended for use inthe mandible or maxilla as anartificial root structure forsingle tooth replacement or forfixed bridgework and dentalretention. The BioHorizonsTapered Implant System maybe restored immediately (1)with a temporary prosthesisthat is not in functionalocclusion or (2) when splintedtogether for multipletooth replacement or whenstabilized with an overdenturesupported by multipleimplants.	The BioHorizonsTapered Internal ImplantSystem is intended for use inthe mandible or maxilla as anartificial root structure forsingle tooth replacement orfor fixed bridgework anddental retention. TheBioHorizons Tapered ImplantSystem may be restoredimmediately (1) with atemporary prosthesis that isnot in functional occlusion or(2) when splinted together formultipletooth replacement or whenstabilized with an overdenturesupported by multipleimplants.	The BioHorizonsTapered Internal ImplantSystem is intended for use inthe mandible or maxilla asan artificial root structure forsingle tooth replacement orfor fixed bridgework anddental retention. TheBioHorizons TaperedImplant System may berestored immediately (1)with a temporary prosthesisthat is not in functionalocclusion or (2) whensplinted together for multipletooth replacement or whenstabilized with anoverdenture supported bymultiple implants.	The IDS device isintended fordelayed loading butdifferences are notsignificant whenused.
Principal MaterialFormulation ofImplants	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Identical
Implant Shape,Diameters andLength	Tapered Shape3.5, 3.8, 4.6, 5.4mm diameters8.0, 10.0, 12.0 mm implantedLengths	Tapered Shape3.0, 3.5, 4.5mm diameters9.0, 10.5, 12.0, 15, 18mmLengths	Parallel wall with 2.5mmapical taper3.0mm diameter10.5, 12.0, 15mm Lengths	Tapered Shape3.5, 4.5, 5.7mm diameters7.5, 9.0, 10.5, 12.0, 15mmLengths	BioHorizons has aslightly smaller andlarger size, butsubject device isbracketed within thelimits of thepredicate. Nosignificantdifferences.
Element ofComparison	510(k) Device:Insight Dental System	Primary Predicate Device:BioHorizons Tapered InternalImplant System K143022	Reference Device:BioHorizons Laser-Lok 3.0Implant System K093321	Reference Device:BioHorizons TaperedInternal Implant SystemK071638	Explanation ofDifferences
Abutments	Abutment diameters3.5, 3.8, 4.6, 5.4mm	N/A (references to K093321)	Abutment diameters3.5, 3.8, 4.2, 4.5, 4.7, 5.5, 5.8,5.9, 6.6, 6.8mm	N/A	BioHorizons hasslightly differentand larger sizes, butsubject device isbracketed within thelimits of thepredicate. Nosignificantdifferences.
Principal MaterialFormulation ofAbutments	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Identical
Healing caps	Healing cap diameters3.5, 3.8, 4.6 and 5.4mm	N/A (references to K093321)	Healing cap diameters3, 3.5, 4.5, 5.7mm	N/A	BioHorizons hasslightly differentand larger sizes, butsubject device isbracketed within thelimits of thepredicate. Nosignificantdifferences.
Principal MaterialFormulation ofHealing caps	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Ti-6AL-4V-ELI	Identical
Principal MaterialFormulation ofClass I Accessories	Stainless Steel	Stainless Steel	Stainless Steel	Stainless Steel	No significantdifferences
Packaging	Tyvek Lidded Blister Tray	Tyvek Lidded Blister Tray	Tyvek Lidded Blister Tray	Tyvek Lidded Blister Tray	No significantdifferences
Sterility	Single Use Gamma Sterilized	Single Use Gamma Sterilized	Single Use Gamma Sterilized	Single Use Gamma Sterilized	Identical

{6}------------------------------------------------

510(k) Premarket Notification Insight Dental Implant System

{7}------------------------------------------------

Summary of Testing

The technological characteristics of the Insight Dental Implant System have been verified to be essentially the same as the predicate devices based on assessments of material composition, dimensional features, mechanical properties and biocompatibility of the implant and instrument materials. Comparative Dynamic Fatigue testing was performed to show equivalence to the predicate device. This testing was performed according to ISO-14801-2007, Dynamic fatigue test for endosseous dental implants for both bone level and tissue level implants.

Surface treatment was evaluated using SEM images, X-ray spectroscopy and auger electron spectroscopy of titanium surfaces.

Cytotoxicity testing according to ISO 10993-5 was also done on the implants materials to demonstrate that the manufacturing process did not change the biocompatibility profile. No additional biocompatibility testing was deemed necessary since the devices are constructed from medical quality titanium.

Shelf life testing has been conducted by accelerated aging according to ASTMF1980-07 and a 1 year shelf life has been established. Shelf life testing included visual inspection, seal strength and bubble testing.

Insight Dental Implant kits are sterilized by gamma irradiation was done to IS01137-1. The Sterility Assurance Level (SAL) for the product sterilization process is 10 . Dosage is a minimum of 25 kGy exposure. Validation was done using the VDmax 25 method (ISO 11137-2). Devices are not labeled as non-pyrogenic.

No clinical test data was used to support the decision of substantial equivalence.

Conclusion:

In accordance with the Federal Food. Drug and Cosmetic Act. 21 CFR Part 807, and based on the information provided in this premarket notifications the Insight Dental Implant System is substantially equivalent to predicate devices as described herein.

Regulation Number and Section

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.